90 related articles for article (PubMed ID: 8140590)
21. Effects of chlorinated diphenyl ethers on the mixed-function oxidases and ultrastructure of rat and trout liver.
Chui YC; Hansell MM; Addison RF; Law FC
Toxicol Appl Pharmacol; 1985 Nov; 81(2):287-94. PubMed ID: 3933142
[TBL] [Abstract][Full Text] [Related]
22. Effects of muroctasin on the activities of drug metabolizing enzymes in liver microsomes of rats.
Kamataki T; Komori M; Iwasaki M; Ohi H; Kitada M; Miura T; Ono K
Arzneimittelforschung; 1988 Jul; 38(7A):1019-22. PubMed ID: 3263867
[TBL] [Abstract][Full Text] [Related]
23. Dietary cholesterol-induced changes of xenobiotic metabolism in liver. II. Effects of phenobarbitone and carbon tetrachloride on activities of drug-metabolizing enzymes.
Hietanen E; Ahotupa M; Heikelä A; Laitinen M
Drug Nutr Interact; 1982; 1(4):313-27. PubMed ID: 6821390
[TBL] [Abstract][Full Text] [Related]
24. Lack of effect of streptogramins on hepatic drug metabolism enzymes in the rat.
Martinet MR; Vedrine Y; Piguet V; Frydman A
Drug Metab Dispos; 1992; 20(4):490-5. PubMed ID: 1356723
[TBL] [Abstract][Full Text] [Related]
25. The influence of acute phenytoin administration on biotransformation and lipid peroxidation in the liver of rats of different ages.
Jahn F; Kadiiska M; Serbinova E; Klinger W; Stoytchev T
Biochem Pharmacol; 1989 Nov; 38(22):4148-51. PubMed ID: 2597187
[No Abstract] [Full Text] [Related]
26. Vanadium: genetical and biochemical investigations.
Bronzetti G; Morichetti E; Della Croce C; Del Carratore R; Giromini L; Galli A
Mutagenesis; 1990 May; 5(3):293-5. PubMed ID: 2200949
[TBL] [Abstract][Full Text] [Related]
27. Activity of xenobiotic metabolizing liver enzymes in Zucker rats.
Huupponen R; Pyykkö K; Ala-Uotila S; Sotaniemi E
Res Commun Chem Pathol Pharmacol; 1991 Jun; 72(3):307-14. PubMed ID: 1947434
[TBL] [Abstract][Full Text] [Related]
28. Unimpaired induction of drug-metabolizing enzymes in hepatocytes isolated from rats with micronodular cirrhosis.
Wu ZQ; Piché D; Vallières S; Huet PM; Gascon-Barré M
Can J Physiol Pharmacol; 1991 Mar; 69(3):426-36. PubMed ID: 2059906
[TBL] [Abstract][Full Text] [Related]
29. A study of liver microsomal enzymes in rats following propoxur (Baygon) administration.
Nelson DL; Lamb DW; Mihail F
Vet Hum Toxicol; 1984 Aug; 26(4):305-8. PubMed ID: 6464348
[TBL] [Abstract][Full Text] [Related]
30. Decrease in brain cytochrome P450 enzyme activities during infection and inflammation of the central nervous system.
Monshouwer M; Agnello D; Ghezzi P; Villa P
Neuroimmunomodulation; 2000; 8(3):142-7. PubMed ID: 11124580
[TBL] [Abstract][Full Text] [Related]
31. Dose-related induction of rat hepatic drug-metabolizing enzymes by diuron and chlorotoluron, two substituted phenylurea herbicides.
Schoket B; Vincze I
Toxicol Lett; 1990 Jan; 50(1):1-7. PubMed ID: 2104995
[TBL] [Abstract][Full Text] [Related]
32. Effects of fumonisin B1 present in Fusarium moniliforme culture material on drug metabolising enzyme activities in ducks.
Raynal M; Bailly JD; Benard G; Guerre P
Toxicol Lett; 2001 May; 121(3):179-90. PubMed ID: 11369472
[TBL] [Abstract][Full Text] [Related]
33. Molecular non-genetic biomarkers related to Fenarimol cocarcinogenesis: organ- and sex-specific CYP induction in rat.
Paolini M; Mesirca R; Pozzetti L; Sapone A; Cantelli-Forti G
Cancer Lett; 1996 Mar; 101(2):171-8. PubMed ID: 8620466
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the effects of risedronate on hepatic microsomal drug metabolizing enzyme activities following administration to rats for 14 days: lack of an induction response.
Smith BJ; Hu JK; Schwecke WP
Drug Chem Toxicol; 1998 Aug; 21(3):291-303. PubMed ID: 9706462
[TBL] [Abstract][Full Text] [Related]
35. Pituitary regulation of sex-specific forms of cytochrome P-450 in liver microsomes of rats.
Kamataki T; Shimada M; Maeda K; Kato R
Biochem Biophys Res Commun; 1985 Aug; 130(3):1247-53. PubMed ID: 3875347
[TBL] [Abstract][Full Text] [Related]
36. Interaction of endosulfan and dietary vitamin A on rat hepatic drug metabolising enzymes.
Sriram K; Misra UK
Acta Vitaminol Enzymol; 1983; 5(4):213-8. PubMed ID: 6424426
[TBL] [Abstract][Full Text] [Related]
37. Biomarkers of effect in evaluating dithianon cocarcinogenesis: selective induction and suppression of murine CYP3A isoform.
Paolini M; Mesirca R; Pozzetti L; Sapone A; Cantelli-Forti G
Cancer Lett; 1997 Feb; 113(1-2):221-8. PubMed ID: 9065825
[TBL] [Abstract][Full Text] [Related]
38. Effect of aroclor 1016 and 1242 on enzyme systems in the rat.
Iverson F; Villeneuve DC; Grant DL; Hatina GV
Bull Environ Contam Toxicol; 1975 Apr; 13(4):456-63. PubMed ID: 805614
[No Abstract] [Full Text] [Related]
39. Role of 3,4-dichlorophenyl methyl sulfone, a metabolite of o-dichlorobenzene, in the changes in hepatic microsomal drug-metabolizing enzymes caused by o-dichlorobenzene administration in rats.
Kato Y; Kimura R
Toxicol Appl Pharmacol; 1997 Aug; 145(2):277-84. PubMed ID: 9266800
[TBL] [Abstract][Full Text] [Related]
40. Pharmacologic toxicity of cimetidine on hepatic and renal drug metabolism.
Solangi KB; Lutton JD; Svogun JA; Ibraham NG; Goodman AI; Levere RD
Res Commun Chem Pathol Pharmacol; 1984 Jul; 45(1):19-35. PubMed ID: 6548043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
